As of June 30, 2024, IVS Group S.A. has 90.45M shares outstanding.
| Shares Outstanding | 90.45M |
As of June 30, 2024, IVS Group S.A. trades at a trailing price-to-earnings ratio of 40.14. The price-to-sales ratio is 0.93, and the price-to-book ratio stands at 86.98.
| PE Ratio | 40.14 |
| PS Ratio | 0.93 |
| PB Ratio | 86.98 |
| P/TBV Ratio | -5.03 |
| P/FCF Ratio | 4.59 |
| P/OCF Ratio | 8.36 |
As of June 30, 2024, IVS Group S.A. trades at an EV/EBITDA multiple of 23.74 - the valuation measure that neutralizes differences in capital structure, tax rates, and depreciation policy, making it the standard yardstick for comparing companies across an industry. The EV/Sales ratio of 1.18 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. Its EV/EBIT multiple of 23.74 values the business against core operating earnings after depreciation, a stricter test than EV/EBITDA for capital-intensive businesses. IVS Group S.A. trades at an EV/FCF ratio of 5.10, comparing the total takeover cost of the business to the cash it actually generates for all capital providers.
| EV / Sales | 1.18 |
| EV / EBITDA | 23.74 |
| EV / EBIT | 23.74 |
| EV / FCF | 5.10 |
As of June 30, 2024, IVS Group S.A. maintains a current ratio of 1.12, meaning it holds 1.1x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 58.98, indicating elevated leverage, while an interest coverage ratio of 1.59 demonstrates limited ability to service its debt obligations.
| Current Ratio | 1.12 |
| Quick Ratio | 0.47 |
| Debt / Equity | 58.98 |
| Debt / EBITDA | 8.46 |
| Interest Coverage | 1.59 |
These figures cover the twelve months ended June 30, 2024. Return on invested capital (ROIC) comes in at 3.51 - the clearest signal of whether the business earns more on its capital than that capital costs, and the core measure of a durable competitive advantage. Return on assets (ROA) stands at 1.29, measuring how efficiently the asset base is converted into earnings. Return on capital employed (ROCE) is 8.18, useful for judging operating efficiency across full business cycles. Inventory turnover of 3.96 indicates how many times IVS Group S.A. sells and replaces its inventory over a year, a key working capital efficiency ratio.
| Return on Assets (ROA) | 1.29 |
| Return on Invested Capital (ROIC) | 3.51 |
| Return on Capital Employed (ROCE) | 8.18 |
| Inventory Turnover | 3.96 |
These figures cover the twelve months ended June 30, 2024. That works out to an effective tax rate of 8.88, which can sit above or below the statutory corporate tax rate depending on foreign earnings mix, tax credits, and one-off items.
| Effective Tax Rate | 8.88 |
Over the twelve months ended June 30, 2024, IVS Group S.A. posted a gross margin of 54.68, reflecting its pricing power and cost economics. The operating margin of 4.96 and net profit margin of 2.31 provide insight into operational efficiency.
| Gross Margin | 54.68 |
| Operating Margin | 4.96 |
| Pretax Margin | 2.61 |
| Profit Margin | 2.31 |
| EBITDA Margin | 4.96 |
These figures cover the twelve months ended June 30, 2024. The dividend payout ratio of 0.79 indicates the proportion of earnings distributed to shareholders, a key gauge of how sustainable the dividend is and how much room remains for future dividend growth. Free cash flow yield stands at 21.80, showing how much cash the business generates relative to its market value - dividends covered by free cash flow are generally more durable than those funded by debt. Total shareholder yield reaches 1.06, combining dividends paid with share buybacks and debt reduction for a fuller picture of capital returned to IVS Group S.A. shareholders.
| Payout Ratio | 0.79 |
| Shareholder Yield | 1.06 |
| FCF Yield | 21.80 |
IVS Group S.A.'s most recent stock split took place on May 9, 2022 with a 1000:1159 split ratio.
| Last Split Date | 5/9/2022 |
| Split Ratio | 1000:1159 |
As of June 30, 2024, IVS Group S.A. has an Altman Z-Score of 1.89, near the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 1.89 |
Already premium?